Mechanistically, IL-1β from the TME was shown to elicit IL-17 production from γδ TILs, leading to the granulocyte colony-stimulating factor (G-CSF)-dependent systemic expansion of neutrophils that suppress cytotoxic CD8+ T cells, allowing increased metastatic disease [134]. The gene discussed is CSF3; the disease is metastatic neoplasm.